Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions.

Wilson SS, Tocchi A, Holly MK, Parks WC, Smith JG.

Mucosal Immunol. 2014 Aug 13. doi: 10.1038/mi.2014.72. [Epub ahead of print]

PMID:
25118165
[PubMed - as supplied by publisher]
2.

Defensins and viral infection: dispelling common misconceptions.

Wiens ME, Wilson SS, Lucero CM, Smith JG.

PLoS Pathog. 2014 Jul 17;10(7):e1004186. doi: 10.1371/journal.ppat.1004186. eCollection 2014 Jul. No abstract available.

PMID:
25033215
[PubMed - in process]
Free PMC Article
3.

Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial.

Lee CT, Chang SS, Kamat AM, Amiel G, Beard TL, Fergany A, Karnes RJ, Kurz A, Menon V, Sexton WJ, Slaton JW, Svatek RS, Wilson SS, Techner L, Bihrle R, Steinberg GD, Koch M.

Eur Urol. 2014 Feb 26. pii: S0302-2838(14)00165-1. doi: 10.1016/j.eururo.2014.02.036. [Epub ahead of print]

PMID:
24630419
[PubMed - as supplied by publisher]
4.

Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial.

Kauf TL, Svatek RS, Amiel G, Beard TL, Chang SS, Fergany A, Karnes RJ, Koch M, O'Hara J, Lee CT, Sexton WJ, Slaton JW, Steinberg GD, Wilson SS, Techner L, Martin C, Moreno J, Kamat AM.

J Urol. 2013 Dec 14. pii: S0022-5347(13)06109-0. doi: 10.1016/j.juro.2013.12.015. [Epub ahead of print]

PMID:
24342144
[PubMed - as supplied by publisher]
5.

Antiviral mechanisms of human defensins.

Wilson SS, Wiens ME, Smith JG.

J Mol Biol. 2013 Dec 13;425(24):4965-80. doi: 10.1016/j.jmb.2013.09.038. Epub 2013 Oct 2. Review.

PMID:
24095897
[PubMed - indexed for MEDLINE]
6.

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin.

Skinner EC, Goldman B, Sakr WA, Petrylak DP, Lenz HJ, Lee CT, Wilson SS, Benson M, Lerner SP, Tangen CM, Thompson IM.

J Urol. 2013 Oct;190(4):1200-4. doi: 10.1016/j.juro.2013.04.031. Epub 2013 Apr 15.

PMID:
23597452
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Critical determinants of human α-defensin 5 activity against non-enveloped viruses.

Gounder AP, Wiens ME, Wilson SS, Lu W, Smith JG.

J Biol Chem. 2012 Jul 13;287(29):24554-62. doi: 10.1074/jbc.M112.354068. Epub 2012 May 25.

PMID:
22637473
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety.

Segarra TJ, Fakioglu E, Cheshenko N, Wilson SS, Mesquita PM, Doncel GF, Herold BC.

PLoS One. 2011;6(11):e27675. doi: 10.1371/journal.pone.0027675. Epub 2011 Nov 11.

PMID:
22096611
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro.

Deb AA, Wilson SS, Rove KO, Kumar B, Koul S, Lim DD, Meacham RB, Koul HK.

J Urol. 2011 Dec;186(6):2426-33. doi: 10.1016/j.juro.2011.07.107. Epub 2011 Oct 21.

PMID:
22019171
[PubMed - indexed for MEDLINE]
10.

Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies.

Scott ME, Wilson SS, Cosentino LA, Richardson BA, Moscicki AB, Hillier SL, Herold BC.

Cytokine. 2011 Nov;56(2):430-4. doi: 10.1016/j.cyto.2011.06.011. Epub 2011 Jul 18.

PMID:
21764598
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Rare bladder tumors: caveat emptor.

Wilson SS, Theodorescu D.

Oncology (Williston Park). 2010 Aug;24(9):838. Review. No abstract available.

PMID:
20923039
[PubMed - indexed for MEDLINE]
12.

Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.

Wilson SS, Cheshenko N, Fakioglu E, Mesquita PM, Keller MJ, Herold BC.

Antivir Ther. 2009;14(8):1113-24. doi: 10.3851/IMP1463.

PMID:
20032541
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Culture-independent microbiological analysis of foley urinary catheter biofilms.

Frank DN, Wilson SS, St Amand AL, Pace NR.

PLoS One. 2009 Nov 12;4(11):e7811. doi: 10.1371/journal.pone.0007811.

PMID:
19907661
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Total pelvic exenteration with a split-thickness skin graft neovagina, continent orthotopic neobladder and rectal reanastomosis, resulting in no external ostomies and adequate sexual function.

de la Garza J, Wilson SS, Behbakht K.

Gynecol Oncol. 2009 Nov;115(2):312-3. doi: 10.1016/j.ygyno.2009.07.002. Epub 2009 Aug 7. No abstract available.

PMID:
19665216
[PubMed - indexed for MEDLINE]
15.

Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety.

Mesquita PM, Cheshenko N, Wilson SS, Mhatre M, Guzman E, Fakioglu E, Keller MJ, Herold BC.

J Infect Dis. 2009 Aug 15;200(4):599-608. doi: 10.1086/600867.

PMID:
19586414
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Novel approaches in fighting herpes simplex virus infections.

Wilson SS, Fakioglu E, Herold BC.

Expert Rev Anti Infect Ther. 2009 Jun;7(5):559-68. doi: 10.1586/eri.09.34. Review.

PMID:
19485796
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A case of tuberous sclerosis complex that progressed to end-stage renal disease.

Sarraf M, Masoumi A, Castro-Silva FJ, Myers JB, Wilson SS, Schrier RW.

Nat Clin Pract Nephrol. 2009 Mar;5(3):172-6. doi: 10.1038/ncpneph1033. Epub 2009 Jan 27.

PMID:
19174772
[PubMed - indexed for MEDLINE]
18.

Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism.

Fakioglu E, Wilson SS, Mesquita PM, Hazrati E, Cheshenko N, Blaho JA, Herold BC.

J Virol. 2008 Oct;82(19):9337-44. doi: 10.1128/JVI.00603-08. Epub 2008 Jul 30.

PMID:
18667508
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model.

Mesquita PM, Wilson SS, Manlow P, Fischetti L, Keller MJ, Herold BC, Shattock RJ.

J Virol. 2008 Jul;82(13):6576-84. doi: 10.1128/JVI.00335-08. Epub 2008 Apr 23.

PMID:
18434407
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.

Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC.

J Infect Dis. 2007 May 1;195(9):1332-9. Epub 2007 Mar 19.

PMID:
17397004
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk